Christopher Heberlig

Christopher Heberlig

Director of Finance/CFO chez KSQ Therapeutics, Inc.

49 ans
Health Technology
Consumer Services
Commercial Services

Profil

Christopher Heberlig was the founder of Kiniksa Pharmaceuticals Ltd.
(founded in 2015) where he held the title of Chief Financial Officer & Executive Vice President.
He is currently the Chief Financial Officer at KSQ Therapeutics, Inc. Mr. Heberlig's former positions include Finance Director & Controller at Panacos Pharmaceuticals, Inc., Principal at EPIX Pharmaceuticals, Inc. and NetGenesis Corp., and Principal at PricewaterhouseCoopers LLP.
He was also the President & Chief Financial Officer at Organovo Holdings, Inc. from 2020 to 2021.
Mr. Heberlig received his undergraduate degree from St. Lawrence University and his MBA from Questrom School of Business.

Postes actifs de Christopher Heberlig

SociétésPosteDébut
Director of Finance/CFO -
Tous les postes actifs de Christopher Heberlig

Anciens postes connus de Christopher Heberlig

SociétésPosteFin
ORGANOVO HOLDINGS, INC. Director of Finance/CFO 07/05/2021
KINIKSA PHARMACEUTICALS, LTD. Founder 20/03/2020
SYNAGEVA BIOPHARMA CORP Corporate Officer/Principal 01/01/2015
Corporate Officer/Principal -
Voir l'expérience en détail de Christopher Heberlig

Formation de Christopher Heberlig

St. Lawrence University Undergraduate Degree
Questrom School of Business Masters Business Admin

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Christopher Heberlig

Relations

65

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées3
PANACOS PHARMACEUTICALS, INC.

Health Technology

KINIKSA PHARMACEUTICALS, LTD.

Health Technology

ORGANOVO HOLDINGS, INC.

Health Technology

Entreprise privées4

Health Technology

Commercial Services

Health Technology

Health Technology

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Christopher Heberlig